
### [NCIT:C4908](http://purl.obolibrary.org/obo/NCIT_C4908)
**Label:** Ovarian Carcinoma

**Subclasses:** [NCIT:C7979](http://purl.obolibrary.org/obo/NCIT_C7979) (Ovarian Endometrioid Adenocarcinoma), [NCIT:C5228](http://purl.obolibrary.org/obo/NCIT_C5228) (Ovarian Cystadenocarcinoma), [NCIT:C7978](http://purl.obolibrary.org/obo/NCIT_C7978) (Ovarian Serous Cystadenocarcinoma), [NCIT:C7700](http://purl.obolibrary.org/obo/NCIT_C7700) (Ovarian Adenocarcinoma), [NCIT:C4026](http://purl.obolibrary.org/obo/NCIT_C4026) (Ovarian Mucinous Cystadenocarcinoma), [NCIT:C5238](http://purl.obolibrary.org/obo/NCIT_C5238) (Ovarian Large Cell Neuroendocrine Carcinoma), [NCIT:C7833](http://purl.obolibrary.org/obo/NCIT_C7833) (Recurrent Ovarian Carcinoma), [NCIT:C105556](http://purl.obolibrary.org/obo/NCIT_C105556) (Low Grade Ovarian Serous Adenocarcinoma), [NCIT:C5243](http://purl.obolibrary.org/obo/NCIT_C5243) (Ovarian Mucinous Adenocarcinoma), [NCIT:C105555](http://purl.obolibrary.org/obo/NCIT_C105555) (High Grade Ovarian Serous Adenocarcinoma), [NCIT:C6256](http://purl.obolibrary.org/obo/NCIT_C6256) (Ovarian Serous Surface Papillary Adenocarcinoma), [NCIT:C5240](http://purl.obolibrary.org/obo/NCIT_C5240) (Ovarian Transitional Cell Carcinoma), [NCIT:C7980](http://purl.obolibrary.org/obo/NCIT_C7980) (Ovarian Clear Cell Cystadenocarcinoma), [NCIT:C7550](http://purl.obolibrary.org/obo/NCIT_C7550) (Ovarian Serous Adenocarcinoma), [NCIT:C40078](http://purl.obolibrary.org/obo/NCIT_C40078) (Ovarian Clear Cell Adenocarcinoma), [NCIT:C36102](http://purl.obolibrary.org/obo/NCIT_C36102) (Hereditary Ovarian Carcinoma), [NCIT:C40440](http://purl.obolibrary.org/obo/NCIT_C40440) (Ovarian Small Cell Carcinoma, Pulmonary Type), [NCIT:C40061](http://purl.obolibrary.org/obo/NCIT_C40061) (Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation), [NCIT:C27390](http://purl.obolibrary.org/obo/NCIT_C27390) (Ovarian Small Cell Carcinoma), [NCIT:C40093](http://purl.obolibrary.org/obo/NCIT_C40093) (Ovarian Squamous Cell Carcinoma), [NCIT:C4509](http://purl.obolibrary.org/obo/NCIT_C4509) (Undifferentiated Ovarian Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C38328](http://purl.obolibrary.org/obo/NCIT_C38328) (Unfavorable Clinical Outcome) 75.00%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 51.92%
- Thing 50.92%
- [NCIT:C7558](http://purl.obolibrary.org/obo/NCIT_C7558) (Endometrial Carcinoma) 45.41%
- [NCIT:C4913](http://purl.obolibrary.org/obo/NCIT_C4913) (Malignant Female Reproductive System Neoplasm) 35.91%
- [NCIT:C36076](http://purl.obolibrary.org/obo/NCIT_C36076) (Malignant Reproductive System Neoplasm) 34.45%
- [NCIT:C3053](http://purl.obolibrary.org/obo/NCIT_C3053) (Female Reproductive System Neoplasm) 34.45%
- [NCIT:C3674](http://purl.obolibrary.org/obo/NCIT_C3674) (Reproductive System Neoplasm) 33.22%
- [NCIT:C2916](http://purl.obolibrary.org/obo/NCIT_C2916) (Carcinoma) 29.98%
- [NCIT:C3709](http://purl.obolibrary.org/obo/NCIT_C3709) (Epithelial Neoplasm) 28.98%
- [NCIT:C4741](http://purl.obolibrary.org/obo/NCIT_C4741) (Neoplasm by Morphology) 27.61%
- [NCIT:C3263](http://purl.obolibrary.org/obo/NCIT_C3263) (Neoplasm by Site) 27.54%
- [NCIT:C3262](http://purl.obolibrary.org/obo/NCIT_C3262) (Neoplasm) 27.47%
- [NCIT:C27551](http://purl.obolibrary.org/obo/NCIT_C27551) (Disorder by Site) 27.27%
- [NCIT:C2991](http://purl.obolibrary.org/obo/NCIT_C2991) (Disease or Disorder) 27.10%


